When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CLRB - Cellectar's CLR 131 Fast Track'd for multiple myeloma; shares up 6%
Cellectar Biosciences Inc.
Thinly traded nano cap Cellectar Biosciences (CLRB+5.6%) is up on more than a 4x surge in volume on the heels of Fast Track status in the U.S. for lead candidate CLR 131 for the fourth line (or greater) treatment of relapsed/refractory multiple myeloma.
More news on: Cellectar Biosciences, Inc., Healthcare stocks news, Stocks on the move,